Abstract:The cat eye syndrome chromosome region candidate 2 (CECR2) protein is an epigenetic regulator involved in chromatin remodeling and transcriptional control. The CECR2 bromodomain (CECR2-BRD) plays a pivotal role in directing the activity of CECR2 through its capacity to recognize and bind acetylated lysine residues on histone proteins. This study elucidates the binding specificity and structural mechanisms of CECR2-BRD interactions with both histone and non-histone ligands, employing techniques such as isothermal titration calorimetry (ITC), nuclear magnetic resonance (NMR) spectroscopy, and a high-throughput peptide assay. The CECR2-BRD selectively binds acetylated histone H3 and H4 ligands, exhibiting a preference for multi-acetylated over mono-acetylated targets. The highest affinity was observed for tetra-acetylated histone H4. Neighboring post-translational modifications, including methylation and phosphorylation, modulate acetyllysine recognition, with significant effects observed for histone H3 ligands. Additionally, this study explored the interaction of the CECR2-BRD with the acetylated RelA subunit of NF-κB, a pivotal transcription factor in inflammatory signaling. Dysregulated NF-kappaB signaling is implicated in numerous pathologies, including cancer progression, with acetylation of RelA at lysine 310 (K310ac) being critical for its transcriptional activity. Recent evidence linking the CECR2-BRD to RelA suggests it plays a role in inflammatory and metastatic pathways, underscoring the need to understand the molecular basis of this interaction. We found the CECR2-BRD binds to acetylated RelA with micromolar affinity, and uses a distinctive binding mode to recognize this non-histone ligand. These results provide new insight on the role of CECR2 in regulating NF-κB-mediated inflammatory pathways. Functional mutagenesis of critical residues, such as Asn514 and Asp464, highlight their roles in ligand specificity and binding dynamics. Notably, the CECR2-BRD remained monomeric in solution and exhibited differential conformational responses upon ligand binding, suggesting adaptive recognition mechanisms. Furthermore, the CECR2-BRD exclusively interacts with nucleosome substrates containing multi-acetylated histones, emphasizing its role in transcriptional activation within euchromatic regions. These findings position the CECR2-BRD as a key chromatin reader and a promising therapeutic target for modulating transcriptional and inflammatory processes, particularly through the development of selective bromodomain inhibitors.

The TRIM33 Bromodomain Recognizes Histone Lysine Lactylation

Targeting bromodomains: epigenetic readers of lysine acetylation

Histone Cross-talk Connects Protein Phosphatase 1α (PP1α) and Histone Deacetylase (HDAC) Pathways to Regulate the Functional Transition of Bromodomain-containing 4 (BRD4) for Inducible Gene Expression

Control of proinflammatory gene programs by regulated trimethylation and demethylation of histone H4K20.

The CECR2 bromodomain displays distinct binding modes to select for acetylated histone proteins versus non-histone ligands.

Systematic profiling of the acetyl lysine machinery reveals a role for MAPKAPK2 in bromodomain inhibitor resistance

Metabolically controlled histone H4K5 acylation/acetylation ratio drives BRD4 genomic distribution

3,5-Dimethylisoxazoles Act As Acetyl-lysine-mimetic Bromodomain Ligands

The bromodomain-containing protein Ibd1 links multiple chromatin related protein complexes to highly expressed genes in Tetrahymena thermophila

Chromatin acetylation associated BRD protein family

Solution Structure of Human Brg1 Bromodomain and Its Specific Binding to Acetylated Histone Tails.

Comprehensive review of histone lactylation: Structure, function, and therapeutic targets

The TRIM14-USP14-BRCC3 Complex Epigenetically Regulates Inflammation Through Inhibiting OPTN-mediated Autophagic Degradation of KDM4D

Does bromodomain flexibility influence histone recognition?

Histone lactylation in macrophage biology and disease: from plasticity regulation to therapeutic implications

ING2 PHD domain links histone H3 lysine 4 methylation to active gene repression

Reversal of Histone Lysine Trimethylation by the JMJD2 Family of Histone Demethylases

Histone H3 lysine 27 crotonylation mediates gene transcriptional repression in chromatin

Chd1 chromodomain links histone H3 methylation with SAGA- and SLIK-dependent acetylation

Regulation of newly identified lysine lactylation in cancer

Impact of Combinatorial Histone Modifications on Acetyllysine Recognition by the ATAD2 and ATAD2B Bromodomains